Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-06-20 07:30 am Purchase | 2024-05-31 | 13D | AKARI THERAPEUTICS PLC SPONSOR AKTX | RPC Pharma Ltd | 112,682,870 19.200% | 25,558,922 (+29.34%) | Filing History |
| 2024-01-04 12:34 pm Purchase | 2024-01-01 | 13D | AKARI THERAPEUTICS PLC SPONSOR AKTX | RPC Pharma Ltd | 87,123,948 26.400% | 23,696,700 (+37.36%) | Filing History |
| 2023-10-20 5:00 pm Purchase | 2023-10-06 | 13D | AKARI THERAPEUTICS PLC SPONSOR AKTX | RPC Pharma Ltd | 63,427,248 21.800% | 60,558,617 (+2111.06%) | Filing History |
| 2023-04-14 4:06 pm Purchase | 2023-03-31 | 13D | AKARI THERAPEUTICS PLC SPONSOR AKTX | RPC Pharma Ltd | 2,868,631 22.700% | 1,700,948 (+145.67%) | Filing History |
| 2022-01-14 4:18 pm Purchase | 2021-12-29 | 13D | AKARI THERAPEUTICS PLC SPONSOR AKTX | RPC Pharma Ltd | 1,167,683 18.000% | 50,575 (+4.53%) | Filing History |
| 2021-10-18 5:06 pm Purchase | 2021-07-07 | 13D | AKARI THERAPEUTICS PLC SPONSOR AKTX | RPC Pharma Ltd | 1,117,108 18.800% | 76,512 (+7.35%) | Filing History |